JP2023541191A5 - - Google Patents
Info
- Publication number
- JP2023541191A5 JP2023541191A5 JP2023516809A JP2023516809A JP2023541191A5 JP 2023541191 A5 JP2023541191 A5 JP 2023541191A5 JP 2023516809 A JP2023516809 A JP 2023516809A JP 2023516809 A JP2023516809 A JP 2023516809A JP 2023541191 A5 JP2023541191 A5 JP 2023541191A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- approximately
- item
- subject
- amyloidosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063078258P | 2020-09-14 | 2020-09-14 | |
| US63/078,258 | 2020-09-14 | ||
| US202063116100P | 2020-11-19 | 2020-11-19 | |
| US63/116,100 | 2020-11-19 | ||
| US202163176015P | 2021-04-16 | 2021-04-16 | |
| US63/176,015 | 2021-04-16 | ||
| PCT/US2021/050316 WO2022056484A1 (en) | 2020-09-14 | 2021-09-14 | Method of treating amyloidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541191A JP2023541191A (ja) | 2023-09-28 |
| JP2023541191A5 true JP2023541191A5 (https=) | 2024-09-26 |
Family
ID=80631942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516809A Pending JP2023541191A (ja) | 2020-09-14 | 2021-09-14 | アミロイドーシスを治療する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230364228A1 (https=) |
| EP (1) | EP4210753A4 (https=) |
| JP (1) | JP2023541191A (https=) |
| KR (1) | KR20230069161A (https=) |
| AU (1) | AU2021339851A1 (https=) |
| CA (1) | CA3192069A1 (https=) |
| IL (1) | IL301047A (https=) |
| MX (1) | MX2023002997A (https=) |
| WO (1) | WO2022056484A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240055101A (ko) * | 2021-09-14 | 2024-04-26 | 시일럼 바이오사이언시즈, 인크. | 다발성 골수종의 치료 방법 |
| KR20250075597A (ko) * | 2022-09-16 | 2025-05-28 | 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 심장 아밀로이드증의 치료를 위한 bag3 방법 및 용도 |
| WO2025194030A1 (en) | 2024-03-15 | 2025-09-18 | Alexion Pharmaceuticals, Inc. | Treatment of mayo stage iiib light chain amyloidosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005299716B2 (en) * | 2004-10-22 | 2012-09-06 | Amgen Inc. | Methods for refolding of recombinant antibodies |
| US20090028847A1 (en) * | 2007-04-12 | 2009-01-29 | Trustees Of Boston University | Multiple myeloma and al amyloid immunotherapy targeting immunoglobulin light chains and uses thereof |
| WO2016189491A1 (en) * | 2015-05-28 | 2016-12-01 | Glaxosmithkline Intellectual Property Development Limited | Novel formulation |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| EP4582446A3 (en) * | 2019-03-05 | 2025-08-13 | Prothena Biosciences Limited | Methods of treating al amyloidosis |
-
2021
- 2021-09-14 CA CA3192069A patent/CA3192069A1/en active Pending
- 2021-09-14 KR KR1020237012401A patent/KR20230069161A/ko active Pending
- 2021-09-14 US US18/026,185 patent/US20230364228A1/en active Pending
- 2021-09-14 WO PCT/US2021/050316 patent/WO2022056484A1/en not_active Ceased
- 2021-09-14 AU AU2021339851A patent/AU2021339851A1/en active Pending
- 2021-09-14 MX MX2023002997A patent/MX2023002997A/es unknown
- 2021-09-14 JP JP2023516809A patent/JP2023541191A/ja active Pending
- 2021-09-14 IL IL301047A patent/IL301047A/en unknown
- 2021-09-14 EP EP21867833.2A patent/EP4210753A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541191A5 (https=) | ||
| US8501705B2 (en) | Methods and materials for treating autoimmune and/or complement mediated diseases and conditions | |
| RU2005127429A (ru) | Активная иммунизация для создания антител к растворимому а-бета | |
| US11591406B2 (en) | Treatment for multiple myeloma (MM) | |
| JP2022513685A5 (https=) | ||
| JP2021526534A5 (https=) | ||
| SG177891A1 (en) | Compositions and methods for treating a neoplasm | |
| JP2015083611A (ja) | 溶血性疾患の処置方法 | |
| JP2024127990A (ja) | アミロイドーシスを処置するための組成物 | |
| JP2025063135A (ja) | Ａｌアミロイドーシスを処置する方法 | |
| JP2024534602A5 (https=) | ||
| Comenzo | Current and Emerging Views and Treatments of Systemic Immunoglobulin Light-Chain (AL) | |
| WO2013140787A1 (ja) | 特発性炎症性筋疾患の予防又は治療剤 | |
| RS54972B1 (sr) | Kombinovana terapija za lečenje raka dojke | |
| EP3345924A1 (en) | Use of cd47 antibodies | |
| JP2024535132A5 (https=) | ||
| EP4592312A1 (en) | Novel antibody for prevention or treatment of fibrotic disease | |
| JP2023504209A5 (https=) | ||
| JP2022520572A5 (https=) | ||
| CN113924099A (zh) | 针对免疫球蛋白轻链的单克隆抗体与抗体产生细胞和其他免疫细胞上的cd38细胞膜分子的组合治疗al淀粉样变性 | |
| JP7217287B2 (ja) | アミロイド症の処置および予防 | |
| UA60331C2 (uk) | Спосіб лікування розсіяного склерозу | |
| CA2740473A1 (en) | Canfosfamide monotherapy for treating multiple myeloma | |
| Van Gameren et al. | Novel treatments for systemic amyloidosis | |
| WO2025067383A1 (zh) | 用TACI-Fc融合蛋白治疗抗体介导性排斥反应的方法 |